Heart failure with preserved ejection fraction: underdiagnosed and undertreated in patients with tricuspid regurgitation

Khawaja M Talha,Marco Metra,Javed Butler
DOI: https://doi.org/10.1093/eurheartj/ehae544
IF: 39.3
2024-09-10
European Heart Journal
Abstract:An illustration of the risk factors, clinical features, possible mechanisms, and management of tricuspid regurgitation and heart failure with preserved ejection fraction ( A–C ). An algorithm outlining the application of validated diagnostic criteria of heart failure with preserved ejection fraction amongst patients with tricuspid regurgitation ( D ). ACC/AHA/HFSA, American College of Cardiology/American Heart Association/Heart Failure Society of America; BMI, body mass index; ESC-HFA, European Society of Cardiology - Heart Failure Association; GLP-1, glucagon-like peptide 1; HFpEF, heart failure with preserved ejection fraction; LV, left ventricle; LVEDP, left ventricular end-diastolic pressure; LVEF, left ventricular ejection fraction; PASP, pulmonary artery systolic pressure; PVD, pulmonary vascular disease; RA, right atrium; RV, right ventricle; SGLT-2, sodium-glucose cotransporter-2; TEER, transcatheter edge-to-edge repair; TR, tricuspid regurgitation; TTVR: transcatheter tricuspid valve replacement.
cardiac & cardiovascular systems
What problem does this paper attempt to address?